BioPharma Credit Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2017
Period Ending	Mar '26 Mar 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2017
Market Capitalization	784	838	859	1,040	982	1,002	Upgrade
Market Cap Growth	-1.99%	-2.43%	-17.41%	5.90%	-2.00%	-5.28%	Upgrade
Enterprise Value	781	809	806	1,031	892	958	Upgrade
Last Close Price	0.69	0.61	0.51	0.54	0.43	0.41	Upgrade
PE Ratio	8.87	8.59	10.09	6.87	15.65	15.35	Upgrade
PS Ratio	6.95	7.00	8.06	5.74	12.80	12.44	Upgrade
PB Ratio	0.93	0.89	0.82	0.94	0.98	0.99	Upgrade
P/TBV Ratio	0.93	0.89	0.82	0.94	0.98	0.99	Upgrade
P/OCF Ratio	10.96	9.38	8.88	6.80	13.79	23.56	Upgrade
EV/Sales Ratio	6.76	6.75	7.56	5.70	11.62	11.88	Upgrade
EV/EBIT Ratio	8.50	8.29	9.46	6.82	14.21	14.67	Upgrade
Net Debt / Equity Ratio	0.00	0.00	-0.10	-0.09	-0.07	-0.14	Upgrade
Asset Turnover	0.13	0.12	0.10	0.16	0.08	0.08	Upgrade
Quick Ratio	7.87	2.09	9.79	5.34	16.51	20.60	Upgrade
Current Ratio	7.87	2.09	9.79	5.34	16.51	20.60	Upgrade
Return on Equity (ROE)	10.35%	9.69%	8.10%	13.50%	6.19%	6.41%	Upgrade
Return on Assets (ROA)	6.44%	5.97%	4.98%	8.33%	3.85%	3.96%	Upgrade
Return on Capital Employed (ROCE)	10.70%	10.30%	8.10%	13.60%	6.20%	6.50%	Upgrade
Earnings Yield	11.46%	11.64%	9.91%	14.55%	6.39%	6.51%	Upgrade
Dividend Yield	10.37%	9.14%	10.79%	10.74%	11.90%	12.47%	Upgrade
Payout Ratio	46.01%	89.23%	63.58%	52.52%	113.20%	107.90%	Upgrade
Buyback Yield / Dilution	7.85%	6.65%	4.00%	0.72%	0.00%	0.00%	Upgrade
Total Shareholder Return	18.10%	15.79%	14.80%	11.46%	11.90%	12.48%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.